B

BMP Pharma Trading AG
XBER:BMP

Watchlist Manager
BMP Pharma Trading AG
XBER:BMP
Watchlist
Price: 5.3 EUR Market Closed
Market Cap: €27.8m

BMP Pharma Trading AG
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

BMP Pharma Trading AG
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BMP Pharma Trading AG
XBER:BMP
Total Equity
€8.9m
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
7%
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Total Equity
€251.8m
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
10%
Bayer AG
XETRA:BAYN
Total Equity
€25.9B
CAGR 3-Years
-13%
CAGR 5-Years
-3%
CAGR 10-Years
1%
Merck KGaA
XETRA:MRK
Total Equity
€28.6B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
8%
Biotest AG
XETRA:BIO
Total Equity
€509.6m
CAGR 3-Years
11%
CAGR 5-Years
2%
CAGR 10-Years
0%
Dermapharm Holding SE
XETRA:DMP
Total Equity
€694.4m
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

BMP Pharma Trading AG
Glance View

Market Cap
27.8m EUR
Industry
N/A

B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.

BMP Intrinsic Value
Not Available

See Also

What is BMP Pharma Trading AG's Total Equity?
Total Equity
8.9m EUR

Based on the financial report for Dec 31, 2024, BMP Pharma Trading AG's Total Equity amounts to 8.9m EUR.

What is BMP Pharma Trading AG's Total Equity growth rate?
Total Equity CAGR 10Y
7%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for BMP Pharma Trading AG have been 14% over the past three years , 10% over the past five years , and 7% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett